Who We Are

CanRIO is a network of Canadian rheumatologists and researchers with expertise in the management of the rheumatic complications of cancer immunotherapy. These include the development of new rheumatic conditions which develop during or after treatment with immunotherapy, termed rheumatic immune related adverse events (Rh ir-AE) and on the management of patients with rheumatic disease who are being treated or being considered for treatment with immunotherapy.

Site content continues to be developed and will be updated on a continuous basis as emerging evidence becomes available.  Please check back frequently!

Read More

Mission Statement

To improve the care of cancer patients across Canada receiving immunotherapy, who develop rheumatic complications or have pre-existing autoimmune conditions, through collaboration, education and research.

Would you like to support CanRIO? Your donation will help fund critical research to help us understand how best to diagnose and treat side effects of immunotherapy in cancer patients. Click on the link below to make a donation through Arthritis Research Canada and enter “CanRIO” in the message area to ensure your support is dedicated to CanRIO research projects.

News from CanRIO

Upcoming Case Rounds

Case Rounds

CanRIO is thrilled to host a “CanRIO Year in Review” for our upcoming international rounds! Join us as we highlight… Read More

Studies from CanRIO

CanRIO Recommendations for the Assessment and…

Coming 2021! With support from the Canadian Rheumatology Association (CRA) Guidelines Committee, CanRIO has assembled a working group of rheumatologists,… Read More

A Prospective Cohort Study of Adults with…

Currently recruiting! This is an ongoing prospective, multi-centre, Canadian study looking at clinical phenotypes, outcomes and biomarker profiles of adults… Read More

General Updates

First international case rounds in the books!

Our first international case rounds was held on February 28th, 2023 with Dr. Marie Kostine as our featured researcher. Rounds… Read More

Welcome to

CanRIO is thrilled to launch the first educational website dedicated to the rheumatic complications of immunotherapy. We hope that this… Read More